Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes
Freedman, Sharon, Amra Hercinovic, David Wallace, Raymond Kraker, Zhuokai Li, Amit Bhatt, Charline Boente, et al. 2022. “Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes”. Ophthalmology 129 (10): 1120-28.